SCHEMBL4897015

SCHEMBL4897015

CCCCC(C)CCC(O)(O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.41
MEN1 O00255 1/20 0.38
CYP3A4 P08684 1/20 0.38
ALOX15 P16050 1/20 0.38
KMT2A Q03164 1/20 0.38
MAPT P10636 1/20 0.37
FDPS P14324 2/20 0.35
LMNA P02545 1/20 0.35
ALDH1A1 P00352 1/20 0.34
DNM1 Q05193 2/20 0.33
TSHR P16473 1/20 0.33
PRKD3 O94806 1/20 0.33
PRKCG P05129 1/20 0.33
PRKCB P05771 1/20 0.33
PRKCA P17252 1/20 0.33
PRKCH P24723 1/20 0.33
PRKCI P41743 1/20 0.33
PRKCE Q02156 1/20 0.33
PRKCQ Q04759 1/20 0.33
PRKCZ Q05513 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4897818 0.93 ACE2 (0.48) ACE2MEN1CYP3A4ALOX15KMT2A
SCHEMBL4894795 0.91 ACE2 (0.52) ACE2MAPTFDPSLMNAPRKD3
SCHEMBL4897448 0.91 ACE2 (0.52) ACE2MAPTFDPSLMNAPRKD3
SCHEMBL4894258 0.91 ACE2 (0.52) ACE2MAPTFDPSLMNAPRKD3
SCHEMBL4898571 0.85 TSHR (0.48) ACE2MEN1CYP3A4ALOX15KMT2A
SCHEMBL12844291 0.81 MEN1 (0.42) ACE2MEN1CYP3A4ALOX15KMT2A
SCHEMBL56652 0.79 LMNA (0.50) ACE2CYP3A4MAPTFDPSLMNA
SCHEMBL10752917 0.78 ACE2 (0.38) ACE2MEN1CYP3A4ALOX15KMT2A
SCHEMBL27516913 0.78 ACE2 (0.38) ACE2MEN1CYP3A4ALOX15KMT2A
SCHEMBL17314985 0.78 ACE2 (0.42) ACE2MEN1CYP3A4ALOX15KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080003277-A1 Agent for improving tissue penetration MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSHAFTEN E.V. (DE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080003277-A1 Agent for improving tissue penetration PGF, MMP8, MMP1 ACE2 1277/4885MEN1 2672/4885CYP3A4 2126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.